The MPTP-treated mouse as a model of Parkinsonism: How good is it?

This publication has 31 references indexed in Scilit:

• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
  Published by Elsevier ,2002
• Mitochondrial Complex I Deficiency in Parkinson's Disease
  Journal of Neurochemistry, 1990
• Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
  New England Journal of Medicine, 1989
• Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease
  Biochemical and Biophysical Research Communications, 1989
• Tetraphenylborate potentiates the respiratory inhibition by the dopaminergic neurotoxin MPP+ in both electron transport particles and intact mitochondria
  Biochemical and Biophysical Research Communications, 1989
• Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP
  Life Sciences, 1986
• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983
• Overview of present day treatment of Parkinson's disease
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1978
• Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1968